Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 88

1.

Immune response to Haemophilus influenzae type b vaccination in patients with chronic renal failure.

Hawdon N, Nix EB, Tsang RS, Ferroni G, McCready WG, Ulanova M.

Clin Vaccine Immunol. 2012 Jun;19(6):967-9. doi: 10.1128/CVI.00101-12. Epub 2012 Apr 25.

2.

Risk of invasive Haemophilus influenzae type b (Hib) disease in adults with secondary immunodeficiency in the post-Hib vaccine era.

Nix EB, Hawdon N, Gravelle S, Biman B, Brigden M, Malik S, McCready W, Ferroni G, Ulanova M.

Clin Vaccine Immunol. 2012 May;19(5):766-71. doi: 10.1128/CVI.05675-11. Epub 2012 Mar 7.

3.

Concentration and avidity of anti-Haemophilus influenzae type b (Hib) antibodies in serum samples obtained from patients for whom Hib vaccination failed.

Breukels MA, Jol-van der Zijde E, van Tol MJ, Rijkers GT.

Clin Infect Dis. 2002 Jan 15;34(2):191-7. Epub 2001 Dec 7.

PMID:
11740707
5.

Immunological characterization of conjugated Haemophilus influenzae type b vaccine failure in infants.

Breukels MA, Spanjaard L, Sanders LA, Rijkers GT.

Clin Infect Dis. 2001 Jun 15;32(12):1700-5. Epub 2001 May 16.

PMID:
11360210
6.

Immunogenicity and reactogenicity to Haemophilus influenzae type B (Hib) conjugate vaccine among rural Alaska adults.

Dentinger CM, Hennessy TW, Bulkow LR, Reasonover AL, Romero-Steiner S, Holder PF, de Leon PG, Carlone GM, Parks DJ, Parkinson AJ, Singleton RJ, Levine OS, Butler JC.

Hum Vaccin. 2006 Jan-Feb;2(1):24-8. Epub 2006 Jan 18.

PMID:
17012896
7.

Haemophilus influenzae type b disease: impact and effectiveness of diphtheria-tetanus toxoids-acellular pertussis (-inactivated poliovirus)/H. influenzae type b combination vaccines.

Schmitt HJ, von Kries R, Hassenpflug B, Hermann M, Siedler A, Niessing W, Clemens R, Weil J.

Pediatr Infect Dis J. 2001 Aug;20(8):767-74.

PMID:
11734739
8.

The development of a new heptavalent diphtheria-tetanus-whole cell pertussis-hepatitis B-Haemophilus influenzae type b-Neisseria meningitidis serogroups A and C vaccine: a randomized dose-ranging trial of the conjugate vaccine components.

Gatchalian S, Palestroque E, De Vleeschauwer I, Han HH, Poolman J, Schuerman L, Dobbelaere K, Boutriau D.

Int J Infect Dis. 2008 May;12(3):278-88. Epub 2007 Nov 5.

9.

Quality of the Haemophilus influenzae type b (Hib) antibody response induced by diphtheria-tetanus-acellular pertussis/Hib combination vaccines.

Denoël PA, Goldblatt D, de Vleeschauwer I, Jacquet JM, Pichichero ME, Poolman JT.

Clin Vaccine Immunol. 2007 Oct;14(10):1362-9. Epub 2007 Aug 15.

10.
11.

Haemophilus influenzae type b vaccine failure in children is associated with inadequate production of high-quality antibody.

Lee YC, Kelly DF, Yu LM, Slack MP, Booy R, Heath PT, Siegrist CA, Moxon RE, Pollard AJ.

Clin Infect Dis. 2008 Jan 15;46(2):186-92. doi: 10.1086/524668.

PMID:
18171249
14.

Combined Haemophilus Influenzae type B-Neisseria meningitidis serogroup C vaccine is immunogenic and well tolerated in preterm infants when coadministered with other routinely recommended vaccines.

Omeñaca F, Arístegui J, Tejedor JC, Moreno-Perez D, Ruiz-Contreras J, Merino JM, Muro Brussi M, Sánchez-Tamayo T, Castro Fernandez J, Cabanillas L, Peddiraju K, Mesaros N, Miller JM.

Pediatr Infect Dis J. 2011 Nov;30(11):e216-24. doi: 10.1097/INF.0b013e3182293a82.

PMID:
21747321
15.
16.

Haemophilus influenzae serotype B (Hib) seroprevalence in England and Wales in 2009.

Ladhani S, Ramsay M, Flood J, Campbell H, Slack M, Pebody R, Findlow J, Newton E, Wilding M, Warrington R, Crawford H, Min S, Gray K, Martin S, Frankland S, Bokuvha N, Laher G, Borrow R.

Euro Surveill. 2012 Nov 15;17(46). pii: 20313.

17.

A synthetic conjugate polysaccharide vaccine against Haemophilus influenzae type b.

Verez-Bencomo V, Fernández-Santana V, Hardy E, Toledo ME, Rodríguez MC, Heynngnezz L, Rodriguez A, Baly A, Herrera L, Izquierdo M, Villar A, Valdés Y, Cosme K, Deler ML, Montane M, Garcia E, Ramos A, Aguilar A, Medina E, Toraño G, Sosa I, Hernandez I, Martínez R, Muzachio A, Carmenates A, Costa L, Cardoso F, Campa C, Diaz M, Roy R.

Science. 2004 Jul 23;305(5683):522-5.

18.

Five-year antibody persistence and safety following a booster dose of combined Haemophilus influenzae type b-Neisseria meningitidis serogroup C-tetanus toxoid conjugate vaccine.

Tejedor JC, Merino JM, Moro M, Navarro ML, Espín J, Omeñaca F, García-Sicilia J, Moreno-Pérez D, Ruiz-Contreras J, Centeno F, Barrio F, Cabanillas L, Muro M, Esporrin C, De Torres MJ, Caubet M, Boutriau D, Miller JM, Mesaros N.

Pediatr Infect Dis J. 2012 Oct;31(10):1074-7.

PMID:
22828645
19.

Safety and immunogenicity of haemophilus influenzae type B polysaccharide or conjugate vaccines in an elderly adult population.

Lottenbach KR, Granoff DM, Barenkamp SJ, Powers DC, Kennedy D, Irby-Moore S, Homan SM, Mink CM.

J Am Geriatr Soc. 2004 Nov;52(11):1883-7.

PMID:
15507066

Supplemental Content

Support Center